[S-8 POS] Monogram Technologies Inc. SEC Filing

Rhea-AI Filing Summary

Monogram Technologies, Inc. filed a Registration Statement on Form S-8 on April 16, 2025 to register the offer and sale of 2,600,000 shares of its common stock, par value $0.001 per share. These shares are allocated for issuance under the Amended and Restated 2019 Stock Option and Grant Plan, enabling the company to grant equity awards to employees and service providers. The filing does not disclose financial results, pricing, or issuance timing.

Positive

• 2,600,000 shares registered for the employee equity plan, supporting retention and incentives
• Filing executed via Form S-8, which is standard and streamlined for employee benefit plans

Negative

• Potential dilution to existing shareholders if all registered shares are later issued
• Filing contains no timing or financial detail on award sizes, vesting, or potential share count changes

Insights

Compensation & Governance Analyst

Registers 2.6M shares for employee equity awards under the 2019 plan.

This filing formally enables issuance of 2,600,000 common shares for equity compensation under the Amended and Restated 2019 Stock Option and Grant Plan. It is an administrative step that permits future grants but does not itself create new shares until awards are issued.

Key dependencies include grant timing, vesting schedules, and any future exercises or share settlements; none are disclosed in this filing. Monitor actual award notices or proxy disclosures for dilution impact and aggregate outstanding share counts over the next 12 months.

As filed with the U.S. Securities and Exchange Commission on October 7, 2025

Registration No. 333-286600

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8 REGISTRATION STATEMENT NO. 333-286600

UNDER

THE SECURITIES ACT OF 1933

Monogram Technologies Inc.

(Exact name of registrant as specified in its charter)

Delaware		81-2349540
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

345 East Main Street

Warsaw, Indiana 46580

(574) 373-3333

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive

offices)

Amended and Restated 2019 Stock Option and Grant Plan

(Full title of the plan)

Chad F. Phipps

Senior Vice President,

General Counsel and Secretary

Zimmer Biomet Holdings, Inc.

345 East Main Street

Warsaw, Indiana 46580

(574) 373-3333

(Name and address, including zip code and telephone number, including area code, of agent for service)

Copy to:

Joseph E. Gilligan

Jessica A. Bisignano

Hogan Lovells US LLP

555 13th Street NW

Washington, DC 20004

(202) 637-5600

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company,” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer		¨		Accelerated filer		¨
Non-accelerated filer		x		Smaller reporting company		x
				Emerging growth company		x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

EXPLANATORY NOTE/DEREGISTRATION OF SECURITIES

This Post-Effective Amendment No. 1 (this “Post-Effective Amendment”) relates to the following Registration Statement on Form S-8 (the “Registration Statement”) filed by Monogram Technologies Inc., a Delaware corporation (the “Registrant”), with the Securities and Exchange Commission (the “SEC”):

● Registration Statement on Form S-8 (No. 333-286600), filed with the SEC on April 16, 2025, registering the offer and sale of 2,600,000 shares of common stock, par value $0.001 per share, of the Registrant for issuance under the Amended and Restated 2019 Stock Option and Grant Plan.

On October 7, 2025, pursuant to the Agreement and Plan of Merger, dated as of July 11, 2025, by and among the Registrant, Zimmer Biomet Holdings, Inc., a Delaware corporation (“Zimmer Biomet”), and Honey Badger Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Zimmer Biomet (“Merger Sub”), as amended by that certain First Amendment to Agreement and Plan of Merger, dated August 27, 2025, by and between the Registrant and Zimmer Biomet, Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly-owned subsidiary of Zimmer Biomet.

As a result of the Merger, the Registrant has terminated all offerings of securities pursuant to the Registration Statement. Accordingly, the Registrant, by filing this Post-Effective Amendment, hereby terminates the effectiveness of the Registration Statement and, in accordance with undertakings made by the Registrant in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that had been registered but remained unsold at the termination of the offering, removes from registration any and all securities of the Registrant registered but unsold under the Registration Statement as of the date hereof.

SIGNATURE

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statement described above to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Warsaw, State of Indiana, on October 7, 2025.

MONOGRAM TECHNOLOGIES INC.
By:	/s/ Chad F. Phipps
	Name:	Chad F. Phipps
	Title:	Senior Vice President and Secretary

No other person is required to sign this Post-Effective Amendment to the Registration Statement in reliance on Rule 478 of the Securities Act of 1933, as amended.

FAQ

What did Monogram Technologies (MGRM) register on Form S-8?

The company registered the offer and sale of 2,600,000 shares of common stock for issuance under the Amended and Restated 2019 Stock Option and Grant Plan.

When was the Form S-8 registration filed for MGRM?

The Registration Statement on Form S-8 was filed on April 16, 2025.

What is the par value of the shares registered by MGRM?

The registered common stock has a par value of $0.001 per share.

Does this filing itself issue new shares for MGRM?

No. The Form S-8 registration permits future offers and sales under the plan but does not itself issue shares; issuance occurs when awards are granted and exercised.

Why do companies file Form S-8 like MGRM did?

Form S-8 registers shares reserved for employee and service-provider equity awards, allowing streamlined reporting when those awards are later granted or exercised.